Copart's strong buy rating is justified by its exceptional 20% ROE, debt-free balance sheet, and impressive $1.5 billion annual operating cash flow. Operating in a duopoly with IAA, Copart's ...
Westaim remains undervalued with skilled management and a strong track record, now boosted by a bullish partnership with CC Capital. The Flywheel effect between Ceres Life and Arena Investors is ...